Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3 β/TTBK pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model

This study confirmed that pramlintide and liraglutide are promising antidiabetic medications that could prevent associated cognitive disorders in different mechanisms.PMID:38536493 | DOI:10.1007/s00424-024-02933-0
Source: Pflugers Archiv : European Journal of Physiology - Category: Physiology Authors: Source Type: research